Cafepharma Today

June 10 2025 - Novo Nordisk starts new CagriSema weightloss drug trial
Novo Nordisk starts new CagriSema weightloss drug trial
Vaccine stocks muted as Wall Street takes 'wait and watch' approach after Kennedy's shake-up
A medical device trade war is brewing between the EU and China
Merck antibody drug for RSV approved by FDA
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Will Biotech Beat This Earnings Season?
Barron's
Monday, October 6, 2014 - 6:05pm
tags:
earnings, Gilead Sciences, Celgene, Biogen Idec
Sanofi And Novo Nordisk‘s Basal-Insulin Battle Continues
Bidness Etc.
Monday, October 6, 2014 - 11:51am
tags:
Sanofi, Novo Nordisk, basal insulin, diabetes, Lantus, Levemir
What a Pain! FDA Fires Back At Critics of its Zohydro Policy
WSJ Pharmalot
Monday, October 6, 2014 - 11:48am
tags:
Zohydro ER, Zogenix, FDA
Why GSK Has Been Immune To Ebola Gains
Bidness Etc.
Monday, October 6, 2014 - 11:46am
tags:
GSK, ebola virus, NewLink Genetics, Tekmira Pharmaceuticals
Vivus announces journal publication of Qsymia study results in type 2 diabetes
Seeking Alpha
Monday, October 6, 2014 - 11:05am
tags:
Vivus, Qsymia, type 2 diabetes
Why Is Sanofi Betting on MannKind Corporation's Afrezza?
Motley Fool
Monday, October 6, 2014 - 10:57am
tags:
Sanofi, MannKind, diabetes, Afrezza
Tekmira: Too Much, Too Soon?
Barron's
Monday, October 6, 2014 - 10:55am
tags:
Tekmira Pharmaceuticals, TKM-EBOLA, ebola virus
Chimerix Wants Its Piece of the Ebola Pie
24/7 Wall St
Monday, October 6, 2014 - 10:54am
tags:
Chimerix, ebola virus, Brincidofovir
Fierce Biotech's Top Women in Biotech 2014
Fierce Biotech
Monday, October 6, 2014 - 9:48am
tags:
biotech
Teva Stops R&D In Other Therapeutic Areas, Including Oncology And Women's Health
NASDAQ.com
Monday, October 6, 2014 - 9:46am
tags:
Teva Pharmaceutical, R&D, oncology, Women's Health
Actavis buying Durata Therapeutics for $616.4
Yahoo/AP
Monday, October 6, 2014 - 9:18am
tags:
Actavis, Durata Therapeutics, M&A
AstraZeneca heart drug gets preferred status in U.S.
Yahoo/Reuters
Monday, October 6, 2014 - 8:40am
tags:
AstraZeneca, Brilinta, acute coronary syndrome
Gilead Outperforms Biotech Sector Over Success Of Sovaldi, Harvoni, And Zydelig
Bidness Etc.
Monday, October 6, 2014 - 7:42am
tags:
Gilead Sciences, Sovaldi, Harvoni, Zydelig
Alcobra ADHD Drug Fails Key Study Except When Patients Removed From Analysis
TheStreet.com
Monday, October 6, 2014 - 7:40am
tags:
Alcobra, ADHD, MDX
Becton Dickinson to Buy CareFusion in Deal Valued at $12.2 Billion
TheStreet.com
Monday, October 6, 2014 - 7:30am
tags:
Becton Dickinson, CareFusion, M&A, devices
Novartis works with Bristol-Myers Squibb to test lung cancer drugs
Yahoo/Reuters
Monday, October 6, 2014 - 7:29am
tags:
Novartis, Bristol-Myers Squibb, lung cancer, Opdivo
The Stunning Mobile Game Changer for Diabetics That Investors Can't Ignore
Motley Fool
Sunday, October 5, 2014 - 10:11am
tags:
Apple, Medtronic, Guardian Mobile, diabetes, DexCom, Senseonics, type 1 diabetes
Record Number of Clinical Trials for Multiple Myeloma this Year
Drug Discovery and Development
Sunday, October 5, 2014 - 10:05am
tags:
Multiple Myeloma
What Are The Best Bets In Biotech?
Investopedia
Sunday, October 5, 2014 - 9:58am
tags:
Amgen, Gilead
'Isis' name association a plague for businesses
triblive, PA
Saturday, October 4, 2014 - 10:15am
tags:
Isis Pharmaceuticals

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.